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Abstract 
Objective: The primary goal of this study was to determine accuracy for diagnosing 
acutely decompensated heart failure (ADHF) in the undifferentiated dyspneic ED patient 
using a Lung and Cardiac Ultrasound (LuCUS) protocol.  Secondary objectives were to 
determine if ultrasound findings acutely change management and if findings are more 
accurate than clinical gestalt. 
Methods: This was a prospective, observational study of adult patients presenting to the 
ED with undifferentiated dyspnea.  Intervention consisted of a twelve-view LuCUS 
protocol performed by experienced emergency physician (EP) sonographers.  The 
primary objective was measured by comparing ultrasound findings to final diagnosis 
independently determined by two blinded physicians.  Acute treatment changes based on 
ultrasound findings were tracked in real time through a standardized data collection form. 
Results: We analyzed data on 99 patients; 36% had a final diagnosis of ADHF.  The 
overall sensitivity, specificity, positive and negative likelihood ratios of the LuCUS 
protocol were 83% (67-93 95% confidence interval [CI]), 83% (70-91 CI), 4.8 (2.7-8.3 
CI) and 0.20 (0.09 – 0.42 CI), respectively.  47% of patients had changes in acute 
management, and 42% had changes in acute treatment. Observed agreement for the 
LuCUS protocol was 93% between coinvestigators.  Overall, accuracy improved by 20% 
(83% vs 63%, 8-31 CI of the difference) over clinical gestalt alone.  
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Conclusion: The LuCUS protocol may accurately identify ADHF and may acutely 
improve clinical management in dyspneic ED patients.  This protocol has improved 
diagnostic accuracy over clinical gestalt alone.  
 
 
INTRODUCTION 
 
Dyspnea, one of the most common complaints evaluated in the emergency 
department (ED), has multiple and varied etiologies.  In the United States, with five 
million people carrying a diagnosis of heart failure, and an additional 650 thousand 
diagnosed annually, patients with acute decompensated heart failure (ADHF) account for 
many of the presentations of acute dyspnea seen in EDs today.1 Early diagnosis and goal-
directed therapies are necessary for these patients in order to increase the efficacy and 
appropriateness of management, avoid unnecessary and potentially harmful interventions, 
as well as avoid delays in care. For example, the use of inhaled bronchodilators, in 
patients with undifferentiated dyspnea later found to have ADHF, is associated with 
worse outcomes.2 Traditional work up for ADHF, using chest radiography and serum 
brain natriuretic peptide, is not always diagnostic or helpful in elucidating the cause of 
dyspnea and has an overall diagnostic accuracy of only 65%.3-7  
 Bedside ultrasonography may play a role in the management of patients with 
undifferentiated dyspnea by allowing early diagnosis of ADHF or by identifying 
alternative etiologies. Multiple prior studies have attempted to differentiate ADHF by 
using lung ultrasound alone to detect pulmonary edema, which appears as diffuse B-lines, 
also termed alveolar interstitial syndrome (AIS).3,5,6,8-11 This finding on bedside 
ultrasound is highly sensitive for ADHF,3,9-13 but lacks specificity as diffuse B-lines can 
be seen in a number of conditions including but not limited to, ADHF, non-cardiogenic 
pulmonary edema, bilateral pneumonia/pneumonitis, and lung cancer.3,8,10,14 
Collapsibility and diameter variation with inspiration of the inferior vena cava 
(IVC) has been extensively studied independently of lung ultrasound.1,15,16 Smaller 
variations in IVC diameter reflect elevated central venous pressure, a finding with a high 
sensitivity for detection of ADHF.1  However, this finding also lacks specificity as 
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elevated central venous pressure can be seen in cardiac tamponade, pulmonary embolism, 
and valvular heart disease.1 
Kajimoto et al were the first to assess lung, cardiac and IVC ultrasound to 
differentiate ADHF from other causes of dyspnea.17  They found their scanning protocol 
to be highly sensitive and specific for diagnosing ADHF when performed by cardiology, 
and more accurate than lung ultrasound alone. Anderson et al later used a protocol similar 
to the Kajimoto study and found a specificity of 100% for diagnosing ADHF.18 Our study 
is similar to these two prior studies in that we also used a scanning protocol, composed of 
lung, cardiac and IVC ultrasound, to diagnose ADHF.  However, our study is the first to 
evaluate the direct impact of ultrasound findings on acute management of dyspneic 
patients.  Also, we chose to evaluate for the presence of pleural effusions, the presence of 
diastolic cardiac dysfunction, and patients previously treated (within 30 minutes) for 
ADHF. We chose to include these additional elements in an effort to improve sensitivity 
for detecting ADHF and allow greater real world application. 
The primary aim of this study was to determine the sensitivity, specificity and 
likelihood ratios for diagnosing ADHF in the undifferentiated dyspneic ED patient using 
a twelve-view Lung and Cardiac Ultrasound (LuCUS) protocol. Our secondary aims were 
to determine if ultrasound findings acutely change management and if these findings 
were more accurate then clinical gestalt alone.  We hypothesize that the use of this 
diagnostic protocol will increase accuracy for diagnosing ADHF and acutely improve 
clinical management. 
 
METHODS 
 
Study Design and Setting 
This was a prospective, observational study on the diagnostic performance of the 
LuCUS protocol to diagnose ADHF in ED patients with undifferentiated dyspnea.  This 
study was conducted at an urban tertiary-care teaching hospital with over 120,000 annual 
ED visits and was approved by the Institutional Review Board. 
 
Study Population 
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We enrolled a convenience sample of patients meeting the inclusion criteria: adult 
patients over 18-years-old and a primary complaint of undifferentiated dyspnea according 
to their treating clinician.  We defined undifferentiated dyspnea as at least two possible 
etiologies in the differential diagnosis, and this did not have to include ADHF as a 
potential diagnosis.  An example of differentiated dyspnea would include a patient with 
known heart failure not compliant with medications or diet restrictions.  We excluded 
patients in whom the treating clinician was confident in their diagnosis after initial 
assessment, patients with an EKG showing ST segment elevation myocardial infarction, 
patients treated for ADHF with nitroglycerin, diuresis or positive pressure ventilation 
greater than 30 minutes prior to ultrasound, patients refusing consent, or patients having 
been enrolled in the study at a prior ED visit.  Both research assistants and physicians 
identified study candidates through a standardized screening process.  Research assistants 
enrolled patients when a study sonographer was available, typically Monday through 
Friday 8 AM to 5 PM. Patients consented to participate prior to enrollment in the study.  
 
Intervention and Data Collection 
After initial history, physical exam, and 12 lead electrocardiogram, but prior to 
ultrasound, treating clinicians were asked by a research assistant to rank ten possible 
etiologies of dyspnea in order of their likelihood (Table 1).  Clinicians only had to rank 
two possible etiologies, but could rank up to ten diagnoses, including ‘other’ where they 
could write in an alternative diagnosis not included on the list.  Treating clinicians 
included board certified Emergency Medicine physicians, Emergency Medicine residents 
(levels PGY 1-4), and third year Internal Medicine residents. 
The LuCUS protocol was performed and interpreted by three investigators; an 
Emergency Medicine ultrasound director and two Emergency Medicine ultrasound 
fellows.  All sonographers had greater than 1,000 previously performed ultrasounds, 
including lung and cardiac exams.  All investigators were required to scan 5 patients at 
the bedside under the direct supervision of the principle investigator to ensure a 
standardized method of acquiring and interpreting images.  Sonographers also spent 4 
hours reviewing left ventricular function in the echocardiography reading room under the 
direction of a board certified cardiologist. 
Sonographers were blinded to the treating clinician’s initial assessment, patients’ 
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comorbidities, and the results of lab tests or imaging studies performed during the 
patients’ ED encounter.  
 
The LuCUS Protocol 
 
Each sonographer conducted a two-part scanning protocol using a Mindray M7 
ultrasound machine.  Patients were in a position of comfort, semi-recumbent, and as close 
to 30 degrees of head-elevation as possible.  
 
The lung portion of the LuCUS exam interrogated four anterior/lateral lung zones in each 
hemi-thorax with a curvilinear probe.14 Sonographers recorded the number of B-lines 
seen between two ribs in each lung zone.  Greater than three B-lines in a rib space was 
considered a “B-profile”.  An exam that had at least two zones, in each hemi-thorax, with 
a B-profile was considered positive for diffuse B-lines or AIS.4,19  
 
The cardiac portion of the LuCUS exam consisted of the following views: 
1. Subxiphoid view: examined IVC diameter and collapsibility during inspiration in the 
long axis.  The IVC diameter was measured two centimeters caudal to the hepatic vein 
inlet20, using M mode with the cursor placed perpendicular to the IVC. An IVC with a 
maximal diameter ≥2 cm and < 50% collapse was considered plethoric.  An IVC with a 
maximal diameter ≤ 2 cm and > 50% collapse was considered collapsible. Intermediate 
was defined as an IVC that did not fit either criteria.  
2. Parasternal long and short-axis views: left ventricular ejection fraction was estimated 
visually in the parasternal long-axis view by wall contraction and thickening21,22.  
Ejection fraction was confirmed in the parasternal short-axis view at the level of the 
papillary muscles. 
 
Unique elements of the of the LuCUS exam 
1.  Assessed for the presence of a pleural effusion in the mid-axillary line in the 
Extended Focused Assessment with Sonography in Trauma (EFAST)23 position 
bilaterally.  
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2. Assessed diastolic function, in the apical four-chamber cardiac view, by measuring 
the ratio of the peak trans-mitral inflow velocity (E) to the average of the septal and 
lateral mitral annular velocities (e’Avg)—E/e’Avg—obtained using pulsed-wave and 
tissue Doppler imaging (TDI), respectively. Diastolic function was graded as normal, 
indeterminate, impaired (grade 1), pseudo-normal (grade 2) or restrictive (grade 3)22,24-
26. Criteria for detecting and grading diastolic dysfunction were pre-defined and 
developed using the recommendations of the American Society for Echocardiography 
(REF) in conjunction with a cardiologist board-certified in echocardiography.  
 
After LuCUS was completed, sonographers reported to the treating clinicians 
their leading diagnosis based on objective ultrasound findings.  The treating clinician 
then re-ranked their differential diagnosis post-ultrasound on a standardized data 
collection form, eliminating any pathology no longer under consideration.  They were 
also asked how the ultrasound findings would affect their management including changes 
in treatment, obtaining a new consult, admission to a different level of care, disposition, 
and overall confidence in their diagnosis. Ten percent of images were randomly selected 
for blind review by coinvestigators to assess the percentage of observed agreement.  
Approximately two-thirds of images were randomly selected for blind review by a 
cardiologist board-certified in echocardiography to assess inter-observer reliability for 
identifying and grading diastolic dysfunction. 
 
Outcome Measures 
 
Demographic information was collected including patient’s age, gender and 
comorbidities.  We also collected vital signs at presentation, admission diagnosis, cardiac 
biomarkers obtained in the ED and ED interventions.  This information was abstracted by 
research assistants, trained in data abstraction according to recommendations from a 
previously published study.27  Abstractors were blinded to ultrasound results and final 
discharge diagnosis.  
ADHF was defined sonographically as a combination of the following findings:  
1. A plethoric IVC plus 
2. At least one B-profile bilaterally or any pleural effusion plus 
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3. Moderately to severely depressed left ventricular ejection fraction or grade 2 or 
3 diastolic dysfunction. 
For ultrasound findings suggesting alternative diagnoses like COPD/asthma, pneumonia, 
non-cardiogenic pulmonary edema, or normal, refer to Figure 1. 
 Final diagnosis was determined independently by two emergency physicians (KC, 
ST) through a rigorous chart review; this diagnosis served as our criterion standard. Chart 
reviewers followed previously published methods,27 which included training, 
standardized data forms and periodic monitoring.  They were not blinded to the study 
hypothesis, but they were blinded to the LuCUS protocol results.  Chart reviewers 
assessed all cases and arrived at their final diagnosis after reviewing all labs, imaging 
studies, medications administered, consults obtained, comprehensive echocardiography 
results and discharge summaries from the index visit.  Each review was performed 
independently and neither reviewer performed any of the ultrasounds for this study.  If 
the reviewers disagreed, a third blinded reviewer made the decision on final diagnosis. 
The impact of the LuCUS protocol was assessed in several ways.  First, by 
determining whether there was a change in the top three etiologies in the differential 
diagnoses pre and post-ultrasound.  Second, whether the top three etiologies in the 
differential diagnosis became more accurate in comparison to the patient’s final 
diagnosis.  Finally, whether the protocol has immediate clinical impact, as evidenced by 
improvement in acute disease-specific ED management and changes in the treating 
clinician’s confidence in their admission diagnosis. 
 
Data Analysis 
A pilot study using the LuCUS protocol was conducted, enrolling twenty ED 
patients with undifferentiated dyspnea.  Analysis of the pilot data showed LuCUS to be 
25% more sensitive and 24% more specific for diagnosing ADHF than for patients in 
whom ultrasound was not used.  From these results, we calculated based on a paired 
comparison, that a sample size of 96 patients would be needed to detect a 30% increase in 
accuracy with an α of 0.05 and a β of 0.20.  Sensitivity, specificity, positive likelihood 
ratios and negative likelihood ratios were calculated and 95% confidence intervals (CIs) 
were derived using SPSS Statistics for Windows (IBM Corp Version 21.0, Armonk, NY).  
A sub-analysis (Table 3) was completed to see which variables, including B-lines, pleural 
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effusions, IVC assessment, and LV function, yielded the highest accuracy.  Kappa and 
observed agreement were used to assess inter-rater reliability between coinvestigators’ 
interpretations of images. Kappa was also used to assess agreement between EPs’ and 
cardiology’s grading of diastolic dysfunction. 
 
 
RESULTS 
Between December 2012 and July 2013, the LuCUS protocol was performed on 
104 patients presenting to the ED with undifferentiated dyspnea.  Demographic and 
clinical information are listed in Table 2.  The flow of the study is presented in Figure 2.  
A total of five patients were excluded, in four patients the ultrasound was not feasible due 
to poor scanning windows and body habitus, and one patient dropped out of the study 
prior to completion of the ultrasound.  
Overall, 36 out of 99 patients had a criterion standard diagnosis of ADHF, while 
63 patients had an alterative final diagnosis. Sensitivity, specificity, accuracy, positive 
likelihood ratio and negative likelihood ratio of the LuCUS protocol are 83% (67-93 CI), 
83% (70-91 CI), 83% (74-89 CI), 4.8 (2.7-8.3 CI) and 0.20 (0.09 – 0.42 CI), respectively. 
Observed agreement for the LuCUS protocol was 93% between coinvestigators, and κ = 
0.82 (CI 0.70 – 0.95). Overall, accuracy improved by 20% (83% vs 63%, 8-31 CI of the 
difference) using the LuCUS protocol over clinical gestalt alone.  Specificity improved 
by 39% (83 vs 44%, 22-51 CI of the difference) and sensitivity decreased by 11% (94 vs 
83%,  -4.4-26 CI of the difference) but this was not statistically significant. Clinicians felt 
more confident in their diagnosis after the LuCUS protocol in 92% of cases. Sensitivity 
and specificity for detecting diastolic dysfunction were 100% (95% CI 0.83-1.0) and 0.47 
(95% CI 0.24-0.71), respectively. Agreement between EPs and cardiology had a 
weighted kappa of κ=0.51 (95% CI 0.35-0.66). 
Pre-Ultrasound (Clinical Gestalt) 
ADHF was listed amongst the top three etiologies in the differential diagnosis in 
69 (70%) out of 99 patients. Of these 69 patients, 34 (49%) had a criterion standard 
diagnosis of ADHF and 35 (51%) had an alternative diagnosis (Figure 3). Thus, the 
sensitivity and specificity of clinical gestalt was 94 and 44, respectively. 
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Post-Ultrasound (LuCUS Protocol) 
ADHF was listed as one of the top three etiologies in the differential diagnosis in 
41 (41%) out of 99 patients.  Of these 41, 30 (73%) had a criterion standard diagnosis of 
ADHF and 11 (27%) had an alternative diagnosis (Figure 2).    
Comparison of Pre to Post-Ultrasound 
Of the initial 69 patients thought to have ADHF pre-ultrasound: 30 (43%) were 
found to have ADHF post-ultrasound and on final diagnosis; 4 (6%) were found to have a 
final diagnosis of ADHF but an alternative post-ultrasound diagnosis; 8 (12%) were 
found to have ADHF post-ultrasound but not on final diagnosis (Figure 3).  Ultrasound 
correctly eliminated ADHF from the differential diagnosis in 27 (39%) patients who were 
found to have an alternative final diagnosis.  No additional patients who were initially 
thought to have an alternative diagnosis pre-ultrasound were identified as having ADHF 
post-ultrasound. 
Treatment prior to Ultrasound 
Twelve patients were treated with positive pressure ventilation, nitroglycerin 
and/or furosemide prior to ultrasound, with an average of 21 minutes (range 3 to 30 
minutes) between treatment and ultrasound.  All 12 patients had a pre-ultrasound 
diagnosis of ADHF.  Of these 12 patients, 9 (75%) were found to have ADHF post-
ultrasound and on final diagnosis; 3 (25%) had an alternative final and post-ultrasound 
diagnosis - two had COPD, one had non-cardiogenic pulmonary edema. 
Changes in Clinical Management based on Ultrasound 
The LuCUS protocol led to seventy individual changes in management amongst 
47 (47%) patients. This included 42 patients with a change in treatment plan, 12 patients 
with a change in disposition (e.g., admitted to a cardiology service versus medicine), 8 
patients with a change in level of care (e.g. telemetry, ICU or catheterization lab), and 8 
patients who received a new consult. Of the 42 patients with changes in treatment, 39 
(93%) received correct disease-specific treatment (evidenced by concordance between 
post-ultrasound diagnosis and final diagnosis). In 3 of the 42 patients (7%), treatment 
changes were made based on ultrasound findings, but in these three the post-ultrasound 
diagnosis and final diagnosis differed. This included one patient with a final diagnosis of 
COPD where albuterol was initially discontinued as the patient was thought to have 
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ADHF post-ultrasound, and discontinuation of fluids in 2 patients felt to have non-
cardiogenic pulmonary edema on ultrasound who were later found to have pneumonia 
and lung cancer as a final diagnosis, respectively.  
Fifty-one out of 99 patients (51%) had a pre-ultrasound differential diagnosis that 
included both ADHF and COPD. Out of these 51 patients, 25 (49%) had changes in ED 
administered medications. These results are summarized in Table 4.  As a result of the 
use of the LuCUS protocol, 24 out of 25 of these patients (96%) received correct disease-
specific treatment (final diagnosis and post-ultrasound diagnosis were concordant). Only 
one patient, with both a pre-ultrasound and final diagnosis of COPD, incorrectly had 
albuterol discontinued as a result of the LuCUS protocol indicating ADHF.  
The LuCUS protocol took an average total time of 12 minutes (SD 4 minutes) to 
complete; the lung portion took an average of 6 minutes, and the cardiac portion, 
including IVC, took 6 minutes.  This time started when the first images were acquired.   
 
DISCUSSION 
Dyspnea is a common complaint in the ED and rapidly identifying the cause can 
pose a challenge for clinicians. In this study we found the LuCUS protocol improved 
diagnostic accuracy over clinical gestalt alone, including improved specificity, which was 
statistically significant.  Clinical gestalt was more sensitive for the diagnosis of ADHF, 
but did not reach statistical significance.  We believe clinical gestalt had such a high 
sensitivity due to ADHF being over-diagnosed.  This is illustrated by the fact that over 
fifty percent of the patients thought to have ADHF based on clinical gestalt (pre-
ultrasound) were ultimately found to have an alternative criterion standard diagnosis. 
The LuCUS protocol had 6 false negative results.  Two of these patients were 
thought to have atrial fibrillation as the primary etiology of dyspnea pre-ultrasound, the 
LuCUS protocol found a mixed diagnosis, which was defined as two etiologies 
contributing equally to the patient’s clinical symptoms.  In these two cases, ADHF was 
one of the two etiologies, so these ultrasounds were coded as a “mixed” diagnosis and not 
as ADHF alone.  However, both of these patients were treated appropriately with 
diuresis.  If these ultrasounds had been coded as ADHF instead of a mixed diagnosis, the 
sensitivity would have improved from 83 to 89% (75-95 CI). 
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 Eleven patients had a false positive ultrasound. Of these 11 patients, 8 were 
thought to have a pre- and post-ultrasound diagnosis of ADHF, meaning they had both a 
clinical and sonographic appearance of ADHF and were treated as such. These 8 patients 
had final diagnoses that included renal failure with non-cardiogenic pulmonary edema, 
atrial fibrillation, pulmonary hypertension with interstitial lung disease, and sternal 
fracture with pulmonary contusion. There are several factors that could explain why these 
patients were found to be false positives.  First, the etiology of their dyspnea on initial 
presentation may have been multifactorial, including, in addition to their final diagnosis, 
ADHF.  This is supported by the fact that in all of these cases the patient had a history of 
ADHF and positive lung findings on ultrasound. Thus, their clinical and sonographic 
appearance is consistent with ADHF while the root cause of their dyspnea (at the index 
visit) is not related to their underlying cardiac condition. Second, since ADHF is a 
dynamic process, 28 it is possible these patients had evidence of ADHF in the ED and 
improved prior to admission after receiving proper treatment. These findings illustrate the 
limitations of the criterion standard used for diagnosing ADHF in this study. If, for 
example, these 8 patients truly had ADHF, the specificity would have improved from 83 
to 95% (87-98 CI).  
The LuCUS protocol had a large impact on acute clinical management, which is 
highly important as disease-specific therapies for acutely dyspneic patients improves 
outcomes2. Almost half of the patients enrolled had changes in ED-administered 
medications, changes in level of care and new consultations.  Thirty-nine of 42 patients 
(93%) received correct disease-specific treatment. Only one patient had disease-specific 
treatment (albuterol) discontinued in error based on false positive ultrasound findings of 
ADHF.   
In the subset of patients thought to have both ADHF and COPD pre-ultrasound, 
24 out of 25 patients (96%) received correct disease-specific treatment post-ultrasound. 
Based on clinical gestalt, twelve out of these 25 patients (48%) were thought to have 
COPD and thus were treated with beta agonists and steroids; after LuCUS diagnosed 
ADHF, beta agonists were correctly discontinued. Final diagnosis confirmed that these 
patients had ADHF, not COPD.  
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This protocol not only differentiated patients with ADHF versus COPD, but it 
also identified alternative causes of dyspnea requiring very different treatment.  For 
example, one patient thought to have ADHF based on clinical gestalt, was diagnosed 
post-ultrasound with a large pericardial effusion with early tamponade physiology and 
was taken immediately for drainage.  
The findings of the LuCUS protocol are similar to other previous studies that 
investigated the utility of bedside ultrasound for diagnosing ADHF. However, there are 
several aspects of our study that make it unique. The study by Kajimoto et al17 differs 
from ours in that their protocol was performed by trained cardiologists, thus limiting its 
utilization by EP’s.  Also, we included patients treated for ADHF prior to ultrasound to 
allow for better real-world application.  The results of our study show that our protocol 
can be accurately applied in this subset of patients.  We also evaluated the direct impact 
of ultrasound findings on acute management of dyspneic patients and found that the 
LuCUS protocol lead to correct disease-specific treatment in the vast majority of treated 
patients.  
The LuCUS protocol utilized four unique elements that differ from prior 
protocols: (1) we included patients treated for ADHF before ultrasound, (2) we used 
bilateral B-profiles, rather than AIS, as a potential indicator of ADHF, (3) we evaluated 
for pleural effusions, and (4) we assessed and graded diastolic dysfunction.  
We chose to include patients who had been treated less than 30 minutes prior to 
ultrasound as we thought this was more applicable to daily practice, as patients may be 
treated by EMS or other front-end providers prior to initial evaluation by an EP.  We 
found in this subset of patients the LuCUS protocol to be 100% accurate. These results 
suggest that we can apply this protocol in patients who have been treated for heart failure 
within 30 minutes. 
Using B-profiles and/or pleural effusions as potentially indicative of ADHF 
allowed us to apply our protocol to a much larger group of patients than previous similar 
studies.  While it is well established that the presence of AIS is fairly sensitive for 
detecting ADHF,3,8,10,14 it is possible to have ADHF without AIS.  By using this 
definition, we found a bilateral B profile and ejection fraction <45% improved sensitivity 
 
 
 13 
for detecting ADHF by 35% (69% vs 34%, 11-53 CI of the difference) compared to AIS 
with ejection fraction < 45%.    
Although previous literature would support the conclusion that pleural effusions 
do not improve diagnostic performance,10 we chose to include pleural effusions as part of 
the protocol, as we hypothesized that their inclusion may improve the protocol’s overall 
accuracy, especially after commencement of treatment.  We found the presence of a 
pleural effusion combined with an ejection fraction < 45% to be 98% specific for ADHF, 
with a positive likelihood ratio of 51.  
Even though we were able to detect diastolic dysfunction 100% of the time, there 
was only moderate agreement between EPs and cardiology for grading the level of 
dysfunction. Its assessment in our study did not lead to substantive improvements in 
recognition of ADHF, as only 2 out of the 36 patients (5%) with a final diagnosis of 
ADHF had isolated diastolic dysfunction. However, we believe evaluation of diastolic 
function represents an area for future investigations as patients with isolated diastolic 
dysfunction will present to the ED in ADHF and are likely to benefit from early 
recognition of this as the etiology of their dyspnea. 
This study has shown that EP sonographers with extensive ultrasound experience 
can make an accurate diagnosis of ADHF, more accurate then clinical gestalt alone, and 
this in turn can improve patient care.  Future directions for this research would include 
assessing a modified protocol with less experienced sonographers to further validate the 
results and to improve its generalizability.   
 
LIMITATIONS 
This study has several limitations that could limit its generalizability.  We 
enrolled a convenience sample of patients at a single institution, which may have 
introduced selection bias, as one of the expert sonographers need to be available for 
enrollment.  In addition, despite being powered to detect a clinically significant 
improvement in accuracy, the overall sample size was small.  
The gold standard for diagnosing ADHF is comprehensive echocardiography in 
combination with clinical symptoms and therapeutic response.  Due to limited resources, 
however, not all patients enrolled in the study had a comprehensive echocardiogram.  If it 
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was performed, it was often not completed in a rapid manner, sometimes not occurring 
until days after admission, thereby limiting its utility as a gold standard.  For our study, 
the gold standard was the final diagnosis determined by two independent expert 
reviewers; this model has served as criterion standard in multiple previous heart failure 
studies.1,11,29-31 It is possible that results of the bedside ultrasound, directly or indirectly, 
were included in patients’ ED chart and thus could act as a potential source of bias for the 
chart reviewers. However, our experience is that this is an infrequent practice at this 
institution and thus we feel the risk for bias is minimal. Also, BNP levels were not 
analyzed for this study as not enough patients had levels available, although it was not a 
requirement for enrollment as its use in the acute setting is not as well supported.32 
Due to limitations imposed by the institutional review board, treating clinicians 
were not blinded to ultrasound results as the use of bedside sonography by EPs is 
considered standard care our institution. Thus, subsequent management may reflect 
results of the ultrasound and therefore the treatment record may not be independent of the 
diagnostic test, which may have influenced the chart reviewers’ determination of final 
diagnosis.  Furthermore, sonographers may have been biased as they could not be blinded 
to the physical appearance of patients. However, we believe that this would be of 
minimal significance as patients were covered, we did not perform a physical exam, and 
clinical gestalt, including physical assessment, has been proven to be unreliable for 
determining etiology of dyspnea.18,33 Lastly, this study was designed as an expert-level 
study with future goals of prospective validation using less experienced sonographers.  
 
 
CONCLUSIONS 
In summary, our findings indicate that the LuCUS protocol, when performed by 
an experienced EP-sonographer in the assessment of ED patients with undifferentiated 
dyspnea, may accurately identify ADHF in dyspneic ED patients and increase the rate of 
correct, disease-specific treatment decisions.  
This protocol has better diagnostic accuracy than clinical gestalt alone and 
increases physician confidence in their diagnosis.  
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TABLES 
Table 1. Dyspnea Differential Diagnosis 
Acute Coronary Syndrome Pleural effusion  
Acutely Decompensated Heart Failure Pneumonia 
COPD/Asthma Pulmonary Embolism 
Lung Cancer Mixed 
Non-cardiogenic pulmonary edema Other 
Abbreviation: COPD=chronic obstructive pulmonary disease 
 
Table 2.  Patient Characteristics 
  
 
ADHF TOTAL 
    n = 36 n = 99 
Age, SD, Range 
 
57±14, 34-91 56±13, 22-91 
Male 
 
23 (63.9) 55 (55.6) 
Medical Comorbidities 
 
  
  Congestive heart failure 23 (63.9) 40 (40.4) 
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  COPD 12 (33.3) 43 (43.4) 
  Coronary artery disease 6 (16.7) 16 (16.2) 
  Hypertension 30 (83) 68 (68.7) 
  Lung cancer 1 (2.8) 10 (10.1) 
  Diabetes 11 (30.6) 29 (29.3) 
  Smoking 6 (16.7) 21 (21.2) 
Vital Signs 
  
  
  Hypotension (SBP<100) 3 (8.3) 5 (5.0) 
  Tachycardia (HR>100) 15(41.7) 36 (36.3) 
  Tachypnea (RR>20) 16 (44.4) 44 (44.4) 
  Fever (>100.4F) 0 (0) 0 (0) 
  Hypoxia (<92%) 4 (11.1) 12 (33.3) 
Disposition 
  
  
  ICU 3 (8.3) 9 (9.1) 
  Catheterization Lab 0 (0) 1 (1) 
  Floor 26 (72.2) 64 (64.6) 
  Observation Unit 4 (11.1) 9 (9.1) 
  Home 3 (8.3) 16 (16.2) 
Final Diagnosis 
  
  
  ADHF 36 (36.3) 
  COPD 24 (24.2) 
  Pneumonia 10 (10.1) 
  Lung cancer 7 (7.1) 
  Pleural effusion 3 (3) 
  Non cardiogenic pulmonary edema 2 (2) 
  Pulmonary embolism 2 (2) 
  Acute coronary syndrome 1 (1) 
  Other  15 (15.1) 
Values are mean ± standard deviation, number (%). Abbreviations: ADHF=acutely 
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decompensated heart failure; COPD=chronic obstructive pulmonary disease; ICU=intensive 
care unit 
 
 
 
Table 3. Performance Characteristics for Diagnosing ADHF 
  Sensitivity Specificity LR (+) LR (-) 
Clinical Gestalt 
(Pre-Ultrasound) 
 
94.4 (81-98) 44.4 (33-56) 1.7 0.12 
LuCUS 
(Post-Ultrasound)   
83.3 (67-93) 82.5 (70-91) 4.8 0.20 
  AIS and EF<45% 34.3 (21-51) 96.8 (89-99) 10.9 0.67 
  B Profile and EF<45% 69.4 (53-82) 93.7 (84-97) 10.9 0.33 
  Pleural effusion and EF<45% 79.4 (63-89) 98.4 (92-99) 51 0.21 
  Plethoric IVC and EF<45% 70.6 (54-83) 81.5 (70-89) 3.8 0.36 
 
Abbreviations: ADHF=acutely decompensated heart failure, EF=ejection fraction, IVC=inferior 
vena cava, LR=likelihood ratio 
 
 
Table 4. Treatment changes in patients with Pre-Ultrasound Differential Diagnosis 
including both ADHF and COPD 
Post (LuCUS) Diagnosis Final Diagnosis Treatment change 
ADHF ADHF Discontinued albuterol 
ADHF ADHF, viral myocarditis Discontinued albuterol 
ADHF ADHF Discontinued albuterol 
COPD COPD Discontinued diuresis 
ADHF ADHF Discontinued albuterol 
ADHF COPD Discontinued albuterol 
ADHF+ACS ADHF, A fib RVR Started diuresis, stopped albuterol 
COPD COPD Discontinued diuresis 
ADHF ADHF Discontinued albuterol 
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NCPE+PNA ARDS +PNA Started IVF 
Tamponade Tamponade Started IVF, Catheterization Lab 
COPD COPD Discontinued diuresis 
ADHF ADHF Discontinued albuterol 
ADHF ADHF Discontinued albuterol 
COPD COPD Discontinued diuresis 
COPD COPD Discontinued diuresis 
ADHF+ACS ADHF, A fib RVR Discontinued albuterol 
COPD COPD Discontinued diuresis, Started albuterol 
ADHF ADHF Discontinued albuterol 
NCPE Renal Failure Dialysis 
COPD +PNA PNA Discontinued diuresis 
COPD COPD Discontinued diuresis 
ADHF ADHF Discontinued albuterol 
ADHF ADHF Discontinued albuterol 
COPD COPD Discontinued diuresis 
Abbreviations: ADHF=acutely decompensated heart failure; ARDS=acute respiratory distress; 
COPD=chronic obstructive pulmonary disease; NCPE=non cardiogenic pulmonary edema 
 
 
FIGURE LEGENDS 
Figure 1: Algorithm for differentiating dyspnea using lung and cardiac ultrasound 
findings. 
 
Figure 2: Patient flow through study, from enrollment to LuCUS (post-ultrasound) 
findings. 
 
Figure 3: Patient flow through study, comparing clinical gestalt (pre-ultrasound) 
diagnosis to criterion standard diagnosis and LuCUS (post-ultrasound). 
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FIGURES 
Figure 1 
 
Abbreviations: ADHF=acutely decompensated heart failure, COPD=chronic obstructive 
pulmonary disease 
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